Little Green Pharma Ltd
ASX:LGP

Watchlist Manager
Little Green Pharma Ltd Logo
Little Green Pharma Ltd
ASX:LGP
Watchlist
Price: 0.115 AUD 4.55% Market Closed
Market Cap: 35m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

LGP Price Targets Summary
Little Green Pharma Ltd

Wall Street analysts forecast LGP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LGP is 0.184 AUD with a low forecast of 0.182 AUD and a high forecast of 0.189 AUD.

LGP Lowest Forecast
Wall Street Target
0.182 AUD
58% Upside
LGP Average Forecast
Wall Street Target
0.184 AUD
60% Upside
LGP Highest Forecast
Wall Street Target
0.189 AUD
64% Upside
Lowest
Price Target
0.182 AUD
58% Upside
Average
Price Target
0.184 AUD
60% Upside
Highest
Price Target
0.189 AUD
64% Upside
Little Green Pharma Ltd Competitors:
Price Targets
C
570
China Traditional Chinese Medicine Holdings Co Ltd
21% Downside
H
3692
Hansoh Pharmaceutical Group Company Ltd
2% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
12% Upside
NUVB
Nuvation Bio Inc
277% Upside
C
570
China Traditional Chinese Medicine Holdings Co Ltd
21% Downside
H
3692
Hansoh Pharmaceutical Group Company Ltd
2% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
12% Upside
NUVB
Nuvation Bio Inc
277% Upside
FUM
Futura Medical PLC
235% Upside

Revenue
Forecast

Revenue Estimate
Little Green Pharma Ltd

For the last 1 year the compound annual growth rate for Little Green Pharma Ltd's revenue is 29%. The projected CAGR for the next 3 years is 25%.

29%
Past Growth
25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Little Green Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Little Green Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
LGP intrinsic value, competitors valuation, and company profile.
DCF Valuation
LGP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LGP stock valuation using valuation multiples.
Wall Street Estimates
LGP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LGP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LGP's stock price target?
Price Target
0.184 AUD

According to Wall Street analysts, the average 1-year price target for LGP is 0.184 AUD with a low forecast of 0.182 AUD and a high forecast of 0.189 AUD.

What is Little Green Pharma Ltd's Revenue forecast?
Projected CAGR
25%

For the last 1 year the compound annual growth rate for Little Green Pharma Ltd's revenue is 29%. The projected CAGR for the next 3 years is 25%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.